Decision Making in Prostate Cancer Screening Using Decision Aids vs Usual Care
نویسندگان
چکیده
منابع مشابه
Shared Decision Making Supported by Patient Decision Aids for Prostate Cancer Screening and Treatment
El cáncer de próstata es un problema importante para los hombres mayores en países desarrollados. Las decisiones acerca del screening y tratamiento del cáncer de próstata se caracterizan por múltiples opciones razonables que parecen “arriesgadas”, donde las preferencias personales de los pacientes son importantes. Se va reconociendo de modo creciente la toma de decisión compartida entre el paci...
متن کاملCommunication and decision making in cancer care: setting research priorities for decision support/patients' decision aids.
The following is a summary report from a special symposium titled, "Translating Research into Practice: Setting a Research Agenda for Clinical Decision Tools in Cancer Prevention, Early Detection, and Treatment," that was held on 23 October 2005 in San Francisco at the Annual Meeting of the Society for Medical Decision Making (SMDM). The symposium was designed to answer the question: "What are ...
متن کاملShared decision-making in prostate cancer screening: A review
Results: Eleven works were selected. Most of them versed on the difficulties found in shared decision-making process as preformed ideas on screening effectiveness, lack of knowledge on the last guidelines by physicians, ignorance on real morbidity associated to prostate cancer diagnosis procedures or on mortality related to prostate cancer. There were found some intervention programmes based on...
متن کاملPhysicians' attitudes about shared decision making for prostate cancer screening.
BACKGROUND AND OBJECTIVES Shared decision making (SDM) for prostate cancer screening (PCS) is recommended for physicians and patients due to the uncertainty regarding the risks and benefits of screening. METHODS We assessed primary care physicians' attitudes and specific factors that may influence the SDM process, including level of training and practice setting. Participants included academi...
متن کاملDecision-making in Prostate Cancer Treatment
Today, most men who have localized prostate cancer at diagnosis and who undergo either active surveillance or curative treatment can expect to have a disease-specific survival of at least 10 years2–4. Even men with metastatic disease can expect increased survival as new therapeutic agents become available and alternative regimes for existing treatments are tried5,6. Those facts, combined with a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA Internal Medicine
سال: 2013
ISSN: 2168-6106
DOI: 10.1001/jamainternmed.2013.9253